Cipla

As a collaborative effort with industry, Hyderabad-based CSIR-IICT transferred the entire process and significant quantities of…

Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs

The company launched a spate of relief efforts for advance testing to safeguard healthcare providers and extend humanitarian care…

Rahul Agarwal, Director, Wealth Discovery, explains how the once beaten-down sector, has recently witnessed sharp uptick with…

Cipla’s Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, is the first AB-rated generic therapeutic equivalent version…

The study, completed in the first attempt, was conducted over a period of 15 months at over 100 sites in the US enrolling 1,400…

With this, Cipla has become the first company to file for the 10 mg variant strength of the product

Research on anti-viral drugs has been on throughout the world for long and many companies have developed molecule shaving…

The company said that it remains committed to maintain highest standards of compliance and will work closely with the agency to…

The theme of the summit was 'Grooming Project and Portfolio Management teams for opportunities and uncertainties' Eminence…